21 USC 822a – Prescription drug take back expansion
(a) Definition of covered entity
In this section, the term “covered entity” means—
(1) a State, local, or tribal law enforcement agency;
(2) a manufacturer, distributor, or reverse distributor of prescription medications;
(3) a retail pharmacy;
(4) a registered narcotic treatment program;
(5) a hospital or clinic with an onsite pharmacy;
(6) an eligible long-term care facility; or
(7) any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications.
(b) Program authorized
Terms Used In 21 USC 822a
- control: means to add a drug or other substance, or immediate precursor, to a schedule under part B of this subchapter, whether by transfer from another schedule or otherwise. See 21 USC 802
- distributor: means a person who so delivers a controlled substance or a listed chemical. See 21 USC 802
- drug: has the meaning given that term by section 321(g)(1) of this title. See 21 USC 802
- Drug Enforcement Administration: means the Drug Enforcement Administration in the Department of Justice. See 21 USC 802
- manufacturer: means a person who manufactures a drug or other substance. See 21 USC 802
- State: means a State of the United States, the District of Columbia, and any commonwealth, territory, or possession of the United States. See 21 USC 802
The Attorney General, in coordination with the Administrator of the Drug Enforcement Administration, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall coordinate with covered entities in expanding or making available disposal sites for unwanted prescription medications.